Elevara Medicines
UK - LondonBiotechnology
Focus: Elevara Medicines is a UK-based biotechnology company focused on small molecule therapeutics for rheumatoid arthritis (RA). The company is in early-stage development with Series A funding.
Profile data last refreshed 20h ago · AI intelligence enriched 2w ago
Funding Stage
SERIES A
Open Jobs
0
About Elevara Medicines
AI assessmentNot HiringNo open roles listed right now. Follow Elevara Medicines to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
ELV001 25 mg
Active Rheumatoid ArthritisClinical Trials (1)
NCT07409103A Study to Assess the Safety and Efficacy of Different Doses of ELV001 to Treat Active Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate and Tumor Necrosis Factor Inhibition (START SYNERGY)
Phase 2Help build intelligence for Elevara Medicines
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.